Skip to main content
SpringerLink
Log in

Methylprednisolone/natalizumab

Epstein-Barr virus (EBV) infection leading to primary CNS diffuse B-cell lymphoma and worsening of primary CNS diffuse B-cell lymphoma: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Moineau-Vallee K, et al. Successful management of natalizumab-associated primary central nervous system lymphoma through autologous stem cell transplant. Current Oncology 28: 203-208, No. 1, Feb 2021. Available from: URL: http://doi.org/10.3390/curroncol28010022

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Methylprednisolone/natalizumab. Reactions Weekly 1847, 304 (2021). https://doi.org/10.1007/s40278-021-92861-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92861-x

Search

Navigation